Literature DB >> 18972432

Management of head and neck paragangliomas: review of 120 patients.

Konstantinos Papaspyrou1, Wolf J Mann, Ronald G Amedee.   

Abstract

BACKGROUND: Head and neck paragangliomas (PGL) are rare, mostly benign tumors. About 10% to 15% of PGL are caused by mutations in the succinate dehydrogenase genes B, C, or D and may appear multifocally. METHODS AND
RESULTS: A retrospective review of 120 patients with 146 head and neck PGL, including 46 carotid body tumors (CBT), 13 vagal tumors, 55 jugulotympanic tumors (JTT), 25 tympanic tumors (TT) and 7 tumors in other locations are included. The internal carotid artery was preserved in 97.5% of CBT resections. Preservation of hearing was achieved in 92% of JTT and 88% of TT resections.
CONCLUSION: According to our experience, the treatment of PGL must be individualized, taking into account the patient's age, medical condition, tumor site and size, multiple occurrences, and preexisting cranial nerve deficits. Tumor control is high whether treatment is by surgery or radiotherapy. Patients with solitary lesions whose disease is potentially resectable with acceptable morbidity are better treated surgically.

Entities:  

Mesh:

Year:  2009        PMID: 18972432     DOI: 10.1002/hed.20967

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

1.  [Endocrine surgery for neck paraganglioma: operation, radiation therapy or wait and scan?].

Authors:  R Schneider; J Ukkat; P Nguyen-Thanh; K Lorenz; S Plontke; C Behrmann; C Sekulla; H Dralle
Journal:  Chirurg       Date:  2012-12       Impact factor: 0.955

2.  No evidence for increased mortality in SDHD variant carriers compared with the general population.

Authors:  Leonie T van Hulsteijn; Berdine Heesterman; Jeroen C Jansen; Jean-Pierre Bayley; Frederik J Hes; Eleonora P M Corssmit; Olaf M Dekkers
Journal:  Eur J Hum Genet       Date:  2015-03-11       Impact factor: 4.246

3.  A comparison of particulate and Onyx embolization in preoperative devascularization of carotid body tumors.

Authors:  Julius Griauzde; Joseph J Gemmete; Neeraj Chaudhary; Aditya S Pandey; Steven E Sullivan; Erin L McKean; Lawerence J Marentette
Journal:  Neuroradiology       Date:  2013-06-22       Impact factor: 2.804

Review 4.  Head and Neck Paragangliomas: An Update on the Molecular Classification, State-of-the-Art Imaging, and Management Recommendations.

Authors:  Edward P Lin; Bennett B Chin; Lauren Fishbein; Toshio Moritani; Simone P Montoya; Shehanaz Ellika; Shawn Newlands
Journal:  Radiol Imaging Cancer       Date:  2022-05

5.  Carotid body tumor encounters over a two-decade period in an academic hospital.

Authors:  Abdulmajeed Altoijry; Hesham Alghofili; Kaisor Iqbal; Talal Altuwaijri; Badr Aljabri; Mussaad Al-Salman
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

6.  Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy.

Authors:  Carlos Suárez; Juan P Rodrigo; William M Mendenhall; Marc Hamoir; Carl E Silver; Vincent Grégoire; Primož Strojan; Hartmut P H Neumann; Rupert Obholzer; Christian Offergeld; Johannes A Langendijk; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-19       Impact factor: 2.503

7.  Carotid body tumor: a 25-year experience.

Authors:  Choakchai Metheetrairut; Chanticha Chotikavanich; Phawin Keskool; Nit Suphaphongs
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-08-02       Impact factor: 2.503

8.  An unusual combined glomus vagale and jugular tumor: A case report.

Authors:  Oukessou Youssef; Abdulhakeem Bushra; Regragui Meryem; Hammouda Yassir; El Bouhmadi Khadija; Rouadi Sami; Abada Redallah; Roubal Mohamed; Mahtar Mohamed
Journal:  Ann Med Surg (Lond)       Date:  2021-10-07

9.  A 22-year Northern Irish experience of carotid body tumours.

Authors:  Stephen O'Neill; Mark O'Donnell; Denis Harkin; Maurice Loughrey; Bernard Lee; Paul Blair
Journal:  Ulster Med J       Date:  2011-09

Review 10.  Head and neck paragangliomas: clinical and molecular genetic classification.

Authors:  Christian Offergeld; Christoph Brase; Svetlana Yaremchuk; Irina Mader; Hans Christian Rischke; Sven Gläsker; Kurt W Schmid; Thorsten Wiech; Simon F Preuss; Carlos Suárez; Tomasz Kopeć; Attila Patocs; Nelson Wohllk; Mahdi Malekpour; Carsten C Boedeker; Hartmut P H Neumann
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.